InMed Pharmaceuticals Inc. ( INM) - Key Metrics
INM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $470.54 | -$1.16 | -$0.67 | -$0.67 |
| 2026Q3 | $0 | -$0.73 | -$0.43 | -$0.43 |
| 2026Q2 | $0.28 | -$0.70 | -$0.82 | -$0.82 |
| 2026Q1 | $0.28 | -$0.44 | -$0.57 | -$0.57 |
| 2025Q4 | $0.89 | -$1.22 | -$0.89 | -$0.89 |
INM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | -8489.59% | -0.27 |
| 2026Q3 | 0% | -0.22 |
| 2026Q2 | 0% | -0.37 |
| 2026Q1 | 0% | -0.90 |
| 2025Q4 | 0% | -0.67 |
INM Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q4 | -42.92% | 6368.04% |
| 2026Q3 | -67.38% | 0% |
| 2026Q2 | -76.98% | 0% |
| 2026Q1 | -25.89% | 0% |
| 2025Q4 | -27.33% | 0% |
INM
Price: $1.38
52 week price:
Earnings Per Share: -2.80 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 53653
Market Capitalization: 7.3 million